Severe hyperthermia following use of vaginal misoprostol for pre-operative cervical priming.
Fong
Y F
YF
Department of Obstetrics and Gynaecology, National University of Singapore, Singapore.
Singh
K
K
Prasad
R N
RN
D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage / Q000009:adverse effects*; D000032:Abortion, Therapeutic; D000282:Administration, Intravaginal; D000328:Adult; D020070:Cervical Ripening; D005260:Female; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D016595:Misoprostol / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy
D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol